Equities

Kim Forest Enterprise Co Ltd

6645:TAI

Kim Forest Enterprise Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)27.95
  • Today's Change0.00 / 0.00%
  • Shares traded20.20k
  • 1 Year change-33.45%
  • Beta--
Data delayed at least 20 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in TWDIncome statement in TWDView more

Year on year Kim Forest Enterprise Co Ltd's revenues fell -38.11% from 670.59m to 415.01m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 42.42m to a loss of 102.47m.
Gross margin11.62%
Net profit margin-32.43%
Operating margin-35.97%
Return on assets-17.72%
Return on equity-29.74%
Return on investment-23.51%
More ▼

Cash flow in TWDView more

In 2023, Kim Forest Enterprise Co Ltd increased its cash reserves by 48.89%, or 61.33m. Cash Flow from Financing totalled 168.87m or 40.69% of revenues. In addition the company used 64.54m for operations while cash used for investing totalled 42.87m.
Cash flow per share-1.88
Price/Cash flow per share--
Book value per share9.76
Tangible book value per share9.65
More ▼

Balance sheet in TWDView more

Kim Forest Enterprise Co Ltd has a Debt to Total Capital ratio of 39.86%, a higher figure than the previous year's 17.11%.
Current ratio1.34
Quick ratio0.9174
Total debt/total equity0.6627
Total debt/total capital0.3986
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.